Gadopentetate dimeglumine enhanced MRI in an anephric patient on dialysis.
Gadopentetate dimeglumine (Gd-DTPA) was injected into an anephric patient on maintenance haemodialysis. Sequential serum Gd levels before and after dialysis demonstrated incomplete removal of the administered dose. No clinical sequelae were observed. Gd-DTPA can be given to patients on dialysis, but like iodinated contrast media, may require more than one session for complete removal.
Choyke
P L
PL
Diagnostic Radiology Department, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, Maryland 20892.
Frank
J A
JA
Webb
D
D
Filling-Katz
M R
MR
D000328:Adult; D001932:Brain Neoplasms / Q000473:pathology; D001933:Brain Stem / Q000473:pathology; D005682:Gadolinium / Q000378:metabolism; D019786:Gadolinium DTPA; D006394:Hemangiosarcoma / Q000473:pathology; D006801:Humans; D007089:Image Enhancement / Q000379:methods*; D008279:Magnetic Resonance Imaging; D008297:Male; D009392:Nephrectomy; D009942:Organometallic Compounds / Q000378:metabolism; D004369:Pentetic Acid / Q000378:metabolism; D006435:Renal Dialysis
D009942:Organometallic Compounds; D004369:Pentetic Acid; D005682:Gadolinium; D019786:Gadolinium DTPA